CE/USFDA Approved Invitrogen SuperScript™ III Reverse Transcriptase(1Order Equals 2000 Tests)

Invitrogen SuperScript III Reverse Transcriptase is a genetically engineered MMLV reverse transcriptase (RT) that was created by introduction of several mutations for reduced RNase H activity, increased half-life, and improved thermal stability. SuperScript III RT offers higher cDNA yields, improved cDNA lengths, improved efficiency on GC-rich target RNAs, and overall better performance than wild-type MMLV and MMLV RNase H-minus enzymes. "FOR RESEARCH PURPOSES ONLY"